Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Cells. 2024 Jun 18;13(12):1055. doi: 10.3390/cells13121055.
Neuroplasticity in the amygdala and its central nucleus (CeA) is linked to pain modulation and pain behaviors, but cellular mechanisms are not well understood. Here, we addressed the role of small-conductance Ca-activated potassium (SK) channels in pain-related amygdala plasticity. The facilitatory effects of the intra-CeA application of an SK channel blocker (apamin) on the pain behaviors of control rats were lost in a neuropathic pain model, whereas an SK channel activator (NS309) inhibited pain behaviors in neuropathic rats but not in sham controls, suggesting the loss of the inhibitory behavioral effects of amygdala SK channels. Brain slice electrophysiology found hyperexcitability of CeA neurons in the neuropathic pain condition due to the loss of SK channel-mediated medium afterhyperpolarization (mAHP), which was accompanied by decreased SK2 channel protein and mRNA expression, consistent with a pretranscriptional mechanisms. The underlying mechanisms involved the epigenetic silencing of the SK2 gene due to the increased DNA methylation of the CpG island of the SK2 promoter region and the change in methylated CpG sites in the CeA in neuropathic pain. This study identified the epigenetic dysregulation of SK channels in the amygdala (CeA) as a novel mechanism of neuropathic pain-related plasticity and behavior that could be targeted to control abnormally enhanced amygdala activity and chronic neuropathic pain.
杏仁核及其中央核(CeA)中的神经可塑性与疼痛调节和疼痛行为有关,但细胞机制尚不清楚。在这里,我们研究了小电导钙激活钾(SK)通道在与疼痛相关的杏仁核可塑性中的作用。在神经病理性疼痛模型中,CeA 内应用 SK 通道阻滞剂(apamin)对对照组大鼠疼痛行为的促进作用消失,而 SK 通道激活剂(NS309)抑制神经病理性大鼠的疼痛行为,但不抑制假手术对照组,表明杏仁核 SK 通道的抑制性行为作用丧失。脑片电生理学发现,由于 SK 通道介导的后超极化(mAHP)丧失,神经病理性疼痛条件下 CeA 神经元的兴奋性增加,这伴随着 SK2 通道蛋白和 mRNA 表达减少,与转录前机制一致。潜在的机制涉及由于 SK2 启动子区域 CpG 岛的 DNA 甲基化增加和神经病理性疼痛时 CeA 中甲基化 CpG 位点的变化,导致 SK2 基因的表观遗传沉默。这项研究确定了杏仁核(CeA)中 SK 通道的表观遗传失调是与神经病理性疼痛相关的可塑性和行为的新机制,可作为控制异常增强的杏仁核活性和慢性神经病理性疼痛的靶点。